ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
128.957,09
2,64%
S&P 500
5.638,94
2,13%
US Dollar vs BRL
5,7456
0,02%
Bitcoin
84.179,64
0,26%
Brent Oil
70,285
0,00%
As Melhores Corretoras Online
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. AMEX
  6. Navidea Biopharmaceuticals Inc (NAVB)

  7. Navidea Biopharmaceuticals Inc (NAVB) Notícias

NAVB

Navidea Biopharmaceuticals (NAVB)

Navidea Biopharmaceuticals Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:AMEX:NAVB
DataHoraFonteTítuloCódigoCompanhia
21/12/202317:32Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:NAVBNavidea Biopharmaceuticals Inc
05/12/202320:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:NAVBNavidea Biopharmaceuticals Inc
01/12/202313:49Edgar (US Regulatory)Form 8-K - Current reportAMEX:NAVBNavidea Biopharmaceuticals Inc
23/10/202314:56Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesAMEX:NAVBNavidea Biopharmaceuticals Inc
05/10/202322:01Business WireNavidea Biopharmaceuticals, Inc. Announces NYSE American’s Decision to Suspend Trading In Its Common StockAMEX:NAVBNavidea Biopharmaceuticals Inc
05/10/202317:21Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:NAVBNavidea Biopharmaceuticals Inc
15/09/202316:42Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsAMEX:NAVBNavidea Biopharmaceuticals Inc
11/09/202301:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:NAVBNavidea Biopharmaceuticals Inc
15/08/202318:53Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:NAVBNavidea Biopharmaceuticals Inc
11/08/202317:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:NAVBNavidea Biopharmaceuticals Inc
10/08/202310:29Business WireNavidea Biopharmaceuticals, Inc. NAVB Requests Oral Hearing With NYSE Hearing PanelAMEX:NAVBNavidea Biopharmaceuticals Inc
31/07/202310:32Business WireNavidea Biopharmaceuticals, Inc. Presses Ahead, Embraces OpportunitiesAMEX:NAVBNavidea Biopharmaceuticals Inc
28/07/202321:23Business WireNavidea Biopharmaceuticals, Inc. Announces NYSE American Has Commenced Delisting Proceedings and Intent to Appeal NYSE American DeterminationAMEX:NAVBNavidea Biopharmaceuticals Inc
27/07/202318:20Business WireNavidea Biopharmaceuticals, Inc. Hires Craig A. Dais, CPA as Chief Financial OfficerAMEX:NAVBNavidea Biopharmaceuticals Inc
13/07/202318:09Business WireNavidea Biopharmaceuticals, Inc. Welcomes Dana J Moss, JD to Board of Directors; Amit Bhalla Steps DownAMEX:NAVBNavidea Biopharmaceuticals Inc
03/07/202317:01Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]AMEX:NAVBNavidea Biopharmaceuticals Inc
30/06/202311:46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:NAVBNavidea Biopharmaceuticals Inc
30/06/202310:16Business WireNavidea Biopharmaceuticals, Inc. Rejects Unsolicited Offer To Acquire Certain AssetsAMEX:NAVBNavidea Biopharmaceuticals Inc
16/06/202318:23Edgar (US Regulatory)Current Report Filing (8-k)AMEX:NAVBNavidea Biopharmaceuticals Inc
16/06/202318:00Edgar (US Regulatory)Securities Registration (section 12(g)) (8-a12g)AMEX:NAVBNavidea Biopharmaceuticals Inc
16/06/202317:54Business WireNavidea Biopharmaceuticals, Inc. Announces Distribution of Series K Preferred Stock to Holders of its Common StockAMEX:NAVBNavidea Biopharmaceuticals Inc
16/06/202314:52Business WireNavidea Biopharmaceuticals, Inc. Receives $7.5 Million Cash from Cardinal Health in Lieu of Contingent Milestone PaymentAMEX:NAVBNavidea Biopharmaceuticals Inc
07/06/202317:00Business WireNavidea Biopharmaceuticals, Inc. Reports First Quarter 2023 Financial Results and Provides Business UpdateAMEX:NAVBNavidea Biopharmaceuticals Inc
02/06/202318:54Business WireNavidea Biopharmaceuticals, Inc. Receives NYSE American NoticeAMEX:NAVBNavidea Biopharmaceuticals Inc
01/06/202318:53Business WireNavidea Biopharmaceuticals, Inc. Welcomes Jill Bieker Stefanelli, Ph.D. to Board of Directors; Alexander L. Cappello Steps DownAMEX:NAVBNavidea Biopharmaceuticals Inc
01/06/202307:03Edgar (US Regulatory)Specialized Disclosure Report (sd)AMEX:NAVBNavidea Biopharmaceuticals Inc
22/05/202319:30Business WireNavidea Biopharmaceuticals, Inc. Investors Purchase $1.1 Million in Preferred Shares at MarketAMEX:NAVBNavidea Biopharmaceuticals Inc
11/05/202318:35Business WireNavidea Biopharmaceuticals, Inc. Promotes Michael Sherman Blue, M.D., FACEP, to Chief Medical OfficerAMEX:NAVBNavidea Biopharmaceuticals Inc
11/05/202317:57Edgar (US Regulatory)Quarterly Report (10-q)AMEX:NAVBNavidea Biopharmaceuticals Inc
08/05/202317:12Business WireNavidea Biopharmaceuticals, Inc. Drives Strategy Forward, Shifts Approach for CommunicationsAMEX:NAVBNavidea Biopharmaceuticals Inc
 Apresentando as notícias mais relevantes sobre:AMEX:NAVB

Seu Histórico Recente

COIN
ASSYUSD
ASSY Index
BIT
S32547
Societe Generale Effekten
COIN
XDNUSD
DigitalNote
BIT
B
Bastogi
LSE
MSG
Milestone Group
NASDAQ
TLT
iShares 20 plus Year Tre...
BIT
UV8CP4
UniCredit Bank
BIT
I10201
XS2858865970 20270910 0.02
BIT
UB0P2W
UniCredit Bank
BIT
UIC606
Unicredit Bank
BIT
P1ONL2
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados

Vá sem anúncios

Assine uma experiência sem anúncios

Sem anúncios

Experimente agora

Manter os anúncios